All news

RUSADA unveils number of potential doping abuse cases among Russian athletes in 2022

The drug meldonium (mildronate) was placed on WADA’s prohibition list on January 1, 2016

MOSCOW, January 25. /TASS/. The Russian Anti-Doping Agency (RUSADA) identified 135 potential violations by Russian athletes involving performance enhancing drugs, a spokeswoman for the agency told TASS on Wednesday.

"RUSADA has registered 135 cases of possible violations of anti-doping regulations between January and December 2022," she said.

RUSADA Director General Veronika Loginova said earlier that up to 25% of all reported anti-doping violations last year among Russian athletes were registered by the agency regarding the use of meldonium, a prohibited substance. Other reported cases of anti-doping violations involved the use of anabolic steroids, diuretics and masking agents.

The drug meldonium (mildronate) was placed on WADA’s prohibition list on January 1, 2016. The presence of this substance in an athlete’s bloodstream during and between competitions is a violation of the anti-doping rules. Meldonium is categorized by WADA’s blacklist as an S4 class substance (hormones and metabolic modulators).

Meldronate is a cardiovascular medication freely available for purchase at pharmacies across Russia without a doctor’s prescription.